Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 4
Submit an article Journal homepage
134
Views
7
CrossRef citations to date
0
Altmetric
Reports

A time series analysis of immune checkpoint inhibitor use in the United States Medicare population: 2014–2019

Pranav Puria Mayo Clinic Alix School of Medicine, Scottsdale, AZ, USAORCID Iconhttps://orcid.org/0000-0002-7150-1078
ORCID Icon,
Denis Cortesea Mayo Clinic Alix School of Medicine, Scottsdale, AZ, USA;b Center for Healthcare Delivery and Policy, Arizona State University, Scottsdale, AZ, USA
&
Sujith Baligac Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USACorrespondence[email protected]
Pages 2004-2007 | Received 21 Jul 2021, Accepted 23 Jul 2021, Published online: 11 Aug 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhiwei Zheng, Ling Fang, Hongfu Cai & Huide Zhu. (2023) Cost–Effectiveness Analysis of Serplulimab as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma. Immunotherapy 15:13, pages 1045-1055.
Read now

Articles from other publishers (6)

Lisa May Ling Tachiki, Daniel S. Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Dane Fritzsche, Andrea Perdue, Julia Majovski, Thomas Pulliam, Daniel A. Goldstein, Joshua Veatch, Joel Ho, Paul T. Nghiem, John A. Thompson & Shailender Bhatia. (2023) Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma. Cancer Immunology, Immunotherapy 72:11, pages 3839-3850.
Crossref
Homan Mohammadi & Jonathan D. Schoenfeld. (2023) Lost in the shadow of giants: The neglected treatment modalities in oncologic trials. Cancer 129:21, pages 3357-3359.
Crossref
Michael P. O’Shea, Suganya Arunachalam Karikalan, Ali Yusuf, Timothy Barry, Eiad Habib, John O’Shea, Michael Killian, Eman Baqal, Srishti Nayak, Rajeev Masson, Joerg Hermann, Shimoli Shah, Chadi Ayoub & Hicham El Masry. (2023) Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditis. Cardio-Oncology 9:1.
Crossref
Eric J. Lehrer, Roman O. Kowalchuk, Jason Gurewitz, Kenneth Bernstein, Douglas Kondziolka, Ajay Niranjan, Zhishuo Wei, L. Dade Lunsford, Kareem R. Fakhoury, Chad G. Rusthoven, David Mathieu, Claire Trudel, Timothy D. Malouff, Henry Ruiz-Garcia, Phillip Bonney, Lindsay Hwang, Cheng Yu, Gabriel Zada, Samir Patel, Christopher P. Deibert, Piero Picozzi, Andrea Franzini, Luca Attuati, Rahul N. Prasad, Raju R. Raval, Joshua D. Palmer, Cheng-chia Lee, Huai-che Yang, William S. Harmsen, Brianna M. Jones, Sonam Sharma, Manmeet S. Ahluwalia, Jason P. Sheehan & Daniel M. Trifiletti. (2023) Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain Metastases. International Journal of Radiation Oncology*Biology*Physics 116:4, pages 858-868.
Crossref
Assaf Berger, Kenneth Bernstein, Juan Diego Alzate, Reed Mullen, Joshua S. Silverman, Erik P. Sulman, Bernadine R. Donahue, Anna C. Pavlick, Jason Gurewitz, Monica Mureb, Janice Mehnert, Kathleen Madden, Amy Palermo, Jeffrey S. Weber, John G. Golfinos & Douglas Kondziolka. (2022) Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?. Journal of Neuro-Oncology 158:3, pages 471-480.
Crossref
Igor Stukalin, Newaz Shubidito Ahmed, Adam M. Fundytus, Alexander S. Qian, Stephanie Coward, Gilaad G. Kaplan, Robert J. Hilsden, Kelly W. Burak, Jeffrey K. Lee, Siddharth Singh & Christopher Ma. (2022) Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996–2030). Gastroenterology 162:4, pages 1098-1110.e2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.